Stock events for Agilon Health, Inc. (AGL)
Agilon Health's stock has experienced significant volatility over the past year. Key events include a drop in share price after the CEO's departure and withdrawal of financial guidance on August 4, 2025, challenging Q2 2025 financial results with a revenue decline and negative medical margin, receipt of a NYSE non-compliance notice on November 7, 2025, and a securities fraud lawsuit filed on February 4, 2026, alleging misleading statements about the company's business and prospects.
Demand Seasonality affecting Agilon Health, Inc.’s stock price
While there is no explicit information detailing specific demand seasonality for Agilon Health's products and services, the company operates within the Medicare Advantage market, which serves seniors. The demand for a new primary care model that rewards patient outcomes is consistently high and accelerating, driven by the ongoing challenges of the fee-for-service system.
Overview of Agilon Health, Inc.’s business
Agilon Health, Inc. is focused on transforming senior care delivery through its value-based enablement platform. The company empowers physician groups to manage Medicare Advantage patients, offering data analytics, care coordination, and risk management. Agilon Health aims to improve care quality, reduce costs, and enhance patient experience by transitioning to a value-based payment model, providing healthcare services through primary care physicians across the United States and deriving revenue from medical services.
AGL’s Geographic footprint
Agilon Health has a significant market presence through partnerships with physician groups across the United States. As of 2024, it had partnerships with 31 physician groups across 14 states and over 30 geographies, with more than 2,700 primary care physicians. Headquartered in Westerville, Ohio, with operations in Austin, Texas, Agilon Health is expanding its physical footprint with new office locations. As of March 31, 2025, the platform served approximately 605,000 total members, including 491,000 Medicare Advantage members.
AGL Corporate Image Assessment
Agilon Health positions itself as a trusted partner empowering physicians to transform healthcare for seniors, built on its commitment to value-based care, improving patient outcomes, and reducing healthcare costs. However, the company's reputation has likely been impacted by the CEO's departure, withdrawal of financial guidance, a securities fraud lawsuit, and a NYSE non-compliance notice.
Ownership
The ownership structure of Agilon Health stock is a mix of institutional, retail, and individual investors. Institutional investors hold about 97.36% of the company's shares, with major holders including Clayton, Dubilier & Rice, LLC, Capital World Investors, and Morgan Stanley Investment Management, Inc. Retail investors collectively own approximately 46.29% of the shares, while company insiders hold about 2.23% as of July 2025.
Ask Our Expert AI Analyst
Price Chart
$0.59